Disclaimer: The information on this page is intended for Healthcare Professionals only.

A Conditional Marketing Authorisation (CMA) has been granted in the EU for the product COVID-19 Vaccine AstraZeneca for active immunisation of individuals aged 18 years and older for the prevention of coronavirus disease 2019 (COVID-19)..

You can find more information here [link to local regulator]

Report an Adverse Event via the Medicines Authority ADR website

If you are concerned about an adverse event, it can be reported via the Medicines Authority ADR website, or via the AstraZeneca adverse reporting site.” Insert <link to country-specific adverse reporting site/tool>

This link will take you to another website. AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.


 

AstraZeneca Reporting

Stay Updated